India Imposes Export Quota of COVID-19 Testing Kits
Exports of COVID-19 rapid antigen testing kits from India for July, August and September will be restricted to 1,176 units per month, the country's Directorate General of Foreign Trade said in an Aug. 17 trade notice. Interested exporters are also “requested” to apply for export licenses through the DGFT's ECOM system for export authorizations, but exports above the 1,176-unit threshold must be applied for online from Aug. 20 to Aug. 30. Licenses are valid for six months, the DGFT said. For an application to be considered, an exporter must submit proof of manufacturing, a copy of a purchase order or invoice and an “undertaking duly signed by the authorized signatory in the company letter head to be submitted by the manufacturer certifying that as on date, all domestic commitments/orders have been filled.”
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
In another notice, the DGFT made the policy official by changing the export status of the test kits from free to restricted.